JP2019530741A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019530741A5 JP2019530741A5 JP2019533291A JP2019533291A JP2019530741A5 JP 2019530741 A5 JP2019530741 A5 JP 2019530741A5 JP 2019533291 A JP2019533291 A JP 2019533291A JP 2019533291 A JP2019533291 A JP 2019533291A JP 2019530741 A5 JP2019530741 A5 JP 2019530741A5
- Authority
- JP
- Japan
- Prior art keywords
- leu
- arg
- ala
- thr
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022105144A JP2022126857A (ja) | 2016-09-02 | 2022-06-29 | 医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383334P | 2016-09-02 | 2016-09-02 | |
| US62/383,334 | 2016-09-02 | ||
| PCT/US2017/049460 WO2018045083A1 (en) | 2016-09-02 | 2017-08-30 | Use of cgrp receptor antagonists in neuroprotection and neurological disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022105144A Division JP2022126857A (ja) | 2016-09-02 | 2022-06-29 | 医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019530741A JP2019530741A (ja) | 2019-10-24 |
| JP2019530741A5 true JP2019530741A5 (https=) | 2020-10-08 |
| JP7123932B2 JP7123932B2 (ja) | 2022-08-23 |
Family
ID=59914517
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533291A Active JP7123932B2 (ja) | 2016-09-02 | 2017-08-30 | 神経保護及び神経疾患におけるｃｇｒｐ受容体アンタゴニストの使用 |
| JP2022105144A Pending JP2022126857A (ja) | 2016-09-02 | 2022-06-29 | 医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022105144A Pending JP2022126857A (ja) | 2016-09-02 | 2022-06-29 | 医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11390654B2 (https=) |
| EP (2) | EP4316595A3 (https=) |
| JP (2) | JP7123932B2 (https=) |
| KR (1) | KR102657418B1 (https=) |
| CN (1) | CN109922820A (https=) |
| AU (1) | AU2017319512A1 (https=) |
| CA (1) | CA3035561A1 (https=) |
| ES (1) | ES2965087T3 (https=) |
| IL (1) | IL265099B2 (https=) |
| WO (1) | WO2018045083A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4316595A3 (en) | 2016-09-02 | 2024-04-17 | Christopher J. Soares | Use of cgrp receptor antagonists in treating glaucoma |
| EP3893918B1 (en) * | 2018-12-10 | 2024-09-25 | Rigshospitalet | Vasodilators for use in the treatment of a retinal ischemic disorder |
| CN118717761A (zh) * | 2024-05-27 | 2024-10-01 | 复旦大学 | 瑞美吉泮在制备治疗/预防阿尔茨海默病药物中的应用 |
| CN119524110B (zh) * | 2024-12-16 | 2026-03-20 | 中国人民解放军军事科学院军事医学研究院 | Cgrp在减轻植入式神经电极免疫排斥中的应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| CH657779A5 (de) | 1982-10-05 | 1986-09-30 | Sandoz Ag | Galenische zusammensetzungen enthaltend calcitonin. |
| IT1164225B (it) | 1983-05-13 | 1987-04-08 | Anic Spa | Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione |
| US4530838A (en) | 1983-07-08 | 1985-07-23 | The Salk Institute For Biological Studies | Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
| JPS62129297A (ja) | 1985-08-09 | 1987-06-11 | Toyo Jozo Co Ltd | カルシトニン遺伝子関連ペプチド誘導体 |
| JPS62231168A (ja) | 1986-03-21 | 1987-10-09 | ハイブリテツク・インコ−ポレイテツド | アナライト−レセプタ−分析用内部標準を設けるための改良法 |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| ES2181691T5 (es) | 1992-06-11 | 2007-10-01 | Alkermes Controlled Therapeutics, Inc. | Sistema de distribucion de proteina eritropoyetina. |
| US5354934A (en) | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| WO1994021665A1 (en) | 1993-03-24 | 1994-09-29 | Amylin Pharmaceuticals, Inc. | Cloned receptors and methods for screening |
| US5698401A (en) | 1995-11-14 | 1997-12-16 | Abbott Laboratories | Use of nuclear magnetic resonance to identify ligands to target biomolecules |
| WO1997041223A1 (en) * | 1996-04-15 | 1997-11-06 | The University Of Miami | Molecular clone of cgrp receptor component protein and uses thereof |
| PT1248643E (pt) * | 2000-01-20 | 2005-10-31 | Yeda Res & Dev | Utilizacao de copolimero 1 e peptidos e polipeptidos congeneres e de celulas t tratadas co estes compostos para terapia neuroprotectora |
| US20050054557A1 (en) | 2002-05-09 | 2005-03-10 | Goldberg Michael M. | Compositions for delivering parathyroid hormone and calcitonin |
| PT1534313E (pt) * | 2002-07-30 | 2013-01-25 | Omeros Corp | Soluções e método de irrigação oftalmológica |
| US7812120B2 (en) | 2003-03-21 | 2010-10-12 | Par Pharmaceutical, Inc. | Nasal calcitonin formulations containing chlorobutanol |
| US20060286129A1 (en) | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| RU2385878C2 (ru) | 2004-02-11 | 2010-04-10 | Амилин Фармасьютикалз, Инк. | Пептид, обладающий свойствами амилина (варианты), и его применение (варианты) |
| EP1718665B1 (en) * | 2004-02-11 | 2013-04-10 | Amylin Pharmaceuticals, LLC | Hybrid polypeptides with selectable properties |
| EP2286840A3 (en) | 2004-11-01 | 2013-09-04 | Amylin Pharmaceuticals, LLC | Treatment of obesity and related diseases |
| WO2007055728A1 (en) | 2005-11-01 | 2007-05-18 | Amylin Pharmaceuticals, Inc. | Treatment of obesity and related disorders |
| US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| BRPI0606992A2 (pt) | 2005-02-11 | 2009-07-28 | Amylin Pharmaceuticals Inc | análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis |
| EP2258382A3 (en) | 2005-03-31 | 2014-05-14 | Amylin Pharmaceuticals, LLC | Amylin and amylin agonists for treating psychiatric diseases and disorders |
| WO2007055743A2 (en) | 2005-11-01 | 2007-05-18 | Amylin Pharmaceuticals, Inc. | Treatment of obesity and related disorders |
| MY153249A (en) | 2005-11-14 | 2015-01-29 | Rinat Neuroscience Corp | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| KR20100098628A (ko) | 2007-11-14 | 2010-09-08 | 아밀린 파마슈티칼스, 인크. | 비만 및 비만 관련 질환 및 장애의 치료 방법 |
| WO2009094172A2 (en) * | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| US8748375B2 (en) | 2009-03-17 | 2014-06-10 | Amylin Pharmaceuticals, Llc | Methods for affecting body composition using amylin agonists |
| US20150031623A1 (en) | 2011-09-29 | 2015-01-29 | Mcw Research Foundation, Inc. | Thrombopoietin receptor ligands for neuroprotection |
| US20140249076A1 (en) | 2011-10-18 | 2014-09-04 | Astrazeneca Pharmaceuticals Lp | Amylin-calcitonin chimeric peptides conjugated to duration enhancing moieties |
| CA2861392C (en) * | 2012-01-26 | 2021-08-17 | Christopher J. Soares | Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use |
| ES2746031T3 (es) * | 2012-02-27 | 2020-03-04 | Bristol Myers Squibb Co | Sal de N-(5S,6S,9R)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5H-ciclohepta[B]piridin-9-IL-4-(2-oxo-2,3-dihidro-1H-imidazo[4,5-B]piridin-1-il)piperidina-1-carboxilato |
| WO2015176017A1 (en) * | 2014-05-16 | 2015-11-19 | Salk Institute For Biological Studies | Compositions and methods for treating metabolic disorders |
| EP4316595A3 (en) | 2016-09-02 | 2024-04-17 | Christopher J. Soares | Use of cgrp receptor antagonists in treating glaucoma |
-
2017
- 2017-08-30 EP EP23195196.3A patent/EP4316595A3/en not_active Withdrawn
- 2017-08-30 CA CA3035561A patent/CA3035561A1/en active Pending
- 2017-08-30 EP EP17769144.1A patent/EP3506925B1/en active Active
- 2017-08-30 JP JP2019533291A patent/JP7123932B2/ja active Active
- 2017-08-30 IL IL265099A patent/IL265099B2/en unknown
- 2017-08-30 KR KR1020197009422A patent/KR102657418B1/ko active Active
- 2017-08-30 US US16/329,596 patent/US11390654B2/en active Active
- 2017-08-30 AU AU2017319512A patent/AU2017319512A1/en not_active Abandoned
- 2017-08-30 CN CN201780067192.XA patent/CN109922820A/zh active Pending
- 2017-08-30 ES ES17769144T patent/ES2965087T3/es active Active
- 2017-08-30 WO PCT/US2017/049460 patent/WO2018045083A1/en not_active Ceased
-
2022
- 2022-06-14 US US17/806,834 patent/US12103951B2/en active Active
- 2022-06-29 JP JP2022105144A patent/JP2022126857A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7485620B2 (en) | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
| JP2019530741A5 (https=) | ||
| US20140322250A1 (en) | Peptides for the Treatment of Multiple Sclerosis and Related Diseases | |
| US20180221450A1 (en) | Formulation Comprising A Stabilized Complex Of Corticotropin Releasing Hormone And Alpha-2 Macroglobulin | |
| JP2008505878A (ja) | 医薬 | |
| AU2002310788B2 (en) | Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists | |
| US20110112018A1 (en) | Method for the Treatment and/or Prophylaxis of Multiple Sclerosis, and Use of Erythropoietin for the Manufacture of a Medicament for the Intermittent and/or Intermittent Prophylaxis of Multiple Sclerosis | |
| EP3506925B1 (en) | Use of cgrp receptor antagonists in treating glaucoma | |
| US9913877B2 (en) | Methods and compositions for the treatment of axonal and neuronal degeneration | |
| WO2011037644A1 (en) | Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy | |
| WO2023215277A1 (en) | Trimeprazine for use in treating trigeminal neuralgia and for reducing pain related thereto | |
| CN101180044B (zh) | 用于自身免疫损伤后中枢神经系统神经再生的egf/ghrp-6组合 | |
| Lewitt et al. | ‘On—off’effects: the new challenge in parkinsonism | |
| KR20260005778A (ko) | 탈수초 질환 치료를 위한 펩타이드 및 IVIg의 병용 요법 | |
| US20240358726A1 (en) | Specific therapeutic medical marijuana doses for stress and pain | |
| EP0623350A1 (de) | Verwendung von Bradykinin-Antagonisten zur Herstellung eines Medikaments zur Prophylaxe oder zum Behandeln der Arteriosklerose | |
| US8664209B2 (en) | Daptomycin for multiple sclerosis | |
| EP4687947A1 (en) | Gip activity modulators and orthostatic intolerance | |
| KR102494794B1 (ko) | 여성 성기능장애의 치료를 위한 약학 조성물 및 방법 | |
| WO1984000008A1 (en) | PHARMACEUTICAL PREPARATION CONTAINING AN alpha-ENDORFINE FRAGMENT | |
| US20130178419A1 (en) | Method of treating pain by administration of nerve growth factor | |
| US20180092960A1 (en) | Method of Modulating the Concentration of Proteins in Cerebrospinal Fluid | |
| WO2015042580A1 (en) | Compositions and methods for treatment of neuropathic pain |